Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies

Unmanipulated haploidentical peripheral blood stem cell transplantation (haplo-PBSCT) has been an established treatment to cure high-risk leukemia/lymphoma. Relapse is the main cause of treatment failure for patients with relapsed/refractory disease or with very high-risk gene mutations such as TP53...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xiao-Ning, Lin, Ji, Wang, Shu-Hong, Huang, Wen-Rong, Li, Fei, Li, Hong-Hua, Chen, Jing, Wang, Li-Jun, Gao, Chun-Ji, Yu, Li, Liu, Dai-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334751/
https://www.ncbi.nlm.nih.gov/pubmed/30143831
http://dx.doi.org/10.1007/s00277-018-3482-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334751/
https://www.ncbi.nlm.nih.gov/pubmed/30143831
http://dx.doi.org/10.1007/s00277-018-3482-7

Ejemplares similares